CareDx Inc (CDNA)
CareDx Inc Statistics
Share Statistics
CareDx Inc has 55.68M shares outstanding. The number of shares has increased by 6.42% in one year.
| 55.68M |
| 6.42% |
| 3.34% |
| 99.99% |
| 52M |
| 70 |
| 0.01% |
Short Selling Information
The latest short interest is 6.5M, so 11.69% of the outstanding shares have been sold short.
| 6.5M |
| 11.69% |
| 11.95% |
| 5.14 |
Valuation Ratios
The PE ratio is 21.5 and the forward PE ratio is 109.35. CareDx Inc's PEG ratio is -0.17.
| 21.5 |
| 109.35 |
| 3.39 |
| 1.9 |
| 2.99 |
| 35.8 |
| -0.17 |
Enterprise Valuation
CareDx Inc has an Enterprise Value (EV) of 1.04B.
| 3.13 |
| -30.7 |
| 27.43 |
| 33.06 |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.07.
| 3.94 |
| 3.72 |
| 0.07 |
| -0.83 |
| 0.9 |
| 0 |
Financial Efficiency
Return on Equity is 13.89% and Return on Invested Capital is 10.09%.
| 13.89% |
| 10.7% |
| 10.09% |
| $518,299.69 |
| $81,597.83 |
| 644 |
| 0.68 |
| 5.62 |
Taxes
| 310K |
| 0.59% |
Stock Price Statistics
The stock price has increased by 40.69% in the last 52 weeks. The beta is 2.18, so CareDx Inc's price volatility has been higher than the market average.
| 2.18 |
| 40.69% |
| 17.51 |
| 22.24 |
| 56.95 |
| 1,019,931 |
Income Statement
In the last 12 months, CareDx Inc had revenue of 333.79M and earned 52.55M in profits. Earnings per share was 1.
| 333.79M |
| 224.16M |
| 40.77M |
| 52.55M |
| -33.99M |
| -53.75M |
| 1 |
Balance Sheet
The company has 114.69M in cash and 28.37M in debt, giving a net cash position of 86.32M.
| 114.69M |
| 28.37M |
| 86.32M |
| -626.24M |
| 489.64M |
| 264.95M |
Cash Flow
In the last 12 months, operating cash flow was 38.05M and capital expenditures 0, giving a free cash flow of 31.56M.
| 38.05M |
| n/a |
| 31.56M |
| 0.6 |
Margins
Gross margin is 67.16%, with operating and profit margins of 12.21% and 15.74%.
| 67.16% |
| 12.21% |
| 15.84% |
| 15.74% |
| -10.18% |
| 12.21% |
| 9.46% |
Dividends & Yields
CDNA does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| 4.65% |
| 2.79% |
Analyst Forecast
The average price target for CDNA is $29, which is 52.2% higher than the current price. The consensus rating is "Buy".
| $29 |
| 52.2% |
| Buy |
| 6 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| 12.68 |
| -33.44% |
Scores
| 5.2 |
| 5 |